M S Lebedkina

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Atopic Dermatitis

Respiratory Syndrome Coronavirus

Clinical Practice

Top Venues

Terapevticheskii arkhiv

This page only lists publications with an associated author ORCID identifier.

Publications

Darya S Fomina, S V Fedosenko, E N Bobrikova, Anton A Chernov, Olgo A Mukhina, M S Lebedkina, Alexander V Karaulov, A Y Nurtazina, Mar'yana A Lysenko
[Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)]. Terapevticheskii arkhiv 95 (7) (2023)
Anna Roppelt, M S Lebedkina, Anton A Chernov, Tat'yana S Kruglova, Olgo A Mukhina, Yu D Yukhnovskaya, F A Samedova, U A Mаrkina, G V Andrenova, Alexander V Karaulov, Mar'yana A Lysenko, Darya S Fomina
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Terapevticheskii arkhiv 95 (1) (2023)
M S Lebedkina, Darya S Fomina, Zinaida Yu Mutovina, U A Mаrkina, P O Bogomolov, Vladimir P Chulanov, Mar'yana A Lysenko, Ekaterina Alexeeva
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study]. Terapevticheskii arkhiv 95 (6) (2023)
Anna Roppelt, M S Lebedkina, Anton A Chernov, Tat'yana S Kruglova, Olgo A Mukhina, Yu D Yukhnovskaya, F A Samedova, U A Mаrkina, G V Andrenova, Alexander V Karaulov, Mar'yana A Lysenko, Darya S Fomina
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Terapevticheskii arkhiv 95 (1) (2023)
M S Lebedkina, Darya S Fomina, Zinaida Yu Mutovina, U A Mаrkina, P O Bogomolov, Vladimir P Chulanov, Mar'yana A Lysenko, Ekaterina Alexeeva
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study]. Terapevticheskii arkhiv 95 (6) (2023)
Darya S Fomina, S V Fedosenko, E N Bobrikova, Anton A Chernov, Olgo A Mukhina, M S Lebedkina, Alexander V Karaulov, A Y Nurtazina, Mar'yana A Lysenko
[Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)]. Terapevticheskii arkhiv 95 (7) (2023)
Anna Roppelt, M S Lebedkina, Anton A Chernov, Tat'yana S Kruglova, Olgo A Mukhina, Yu D Yukhnovskaya, F A Samedova, U A Mаrkina, G V Andrenova, Alexander V Karaulov, Mar'yana A Lysenko, Darya S Fomina
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Terapevticheskii arkhiv 95 (1) (2023)
Darya S Fomina, Olgo A Mukhina, M S Lebedkina, M K Gadzhieva, E N Bobrikova, D O Sinyavkin, Vasiliy V Parshin, Anton A Chernov, Andrey Belevskiy
[Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice]. Terapevticheskii arkhiv 94 (3) (2022)
U A Mаrkina, Darya S Fomina, M S Lebedkina, Tat'yana S Kruglova, Anton A Chernov, A I Zagrebneva, Zinaida Yu Mutovina, Alexander V Karaulov, Ekaterina Alexeeva, Mar'yana A Lysenko
[Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit]. Terapevticheskii arkhiv 94 (5) (2022)